---

Musculoskeletal Conditions

I declare an interest in that my family is affected by rheumatoid arthritis. Does the hon. Gentleman agree that drug access is absolutely central to the problem, particularly the new biological anti-TNF drugs, and that their prudent and early use may not only help the patient tremendously, but have a massive societal and economic impact and reduce further costs for the NHS in the longer term? We must ensure that those drugs are used effectively and quickly.